Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome

L. Sokol, L. Cripe, H. Kantarjian, M. A. Sekeres, S. Parmar, P. Greenberg, S. L. Goldberg, V. Bhushan, J. Shammo, R. Hohl, A. Verma, G. Garcia-Manero, Y. P. Li, A. Lowe, J. Zhu, A. F. List

Research output: Contribution to journal › Letter › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome'. Together they form a unique fingerprint.